Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis JAMA Psychiatry (IF21.596), Pub Date : 2022-02-01, DOI: 10.1001/jamapsychiatry.2021.3710 Rakshathi Basavaraju, Jia Guo, Scott A. Small, Jeffrey A. Lieberman, Ragy R. Girgis, Frank A. Provenzano
This study examines the association between increased hippocampal glutamate and higher total positive symptom severity in converters to psychosis.